Abstract

BackgroundBovine neonatal pancytopenia (BNP) is a haemorrhagic disease of neonatal calves. BNP was first described in Germany in 2009, later on also in other European countries, and in New Zealand in 2011. The disease is characterised by spontaneous bleeding, pancytopaenia in the bone marrow, and a high case fatality ratio. The causal role of a specific bovine viral diarrhoea virus (BVDV) vaccine (PregSure®BVD, then Pfizer Animal Health, now Zoetis, Berlin, Germany) has been established over the last years, causing the production of alloantibodies in some vaccinated cattle, which in the case of pregnant cattle, are transferred to the newborn calf via the colostrum. However, striking regional differences in the incidence of the disease were observed within Germany and other countries, but as the disease was not notifiable, no representative data on the spatial distribution are available. In this study, we address the spatial distribution and incidence of BNP using the results of two representative surveys amongst cattle practitioners in Bavaria, Germany. The surveys, asking about the occurrence of BNP, were conducted in 2009 and 2010. Answers were analysed spatially by testing for clusters using space-time models. Practitioners were also asked how many cows they serve in their practice and this number was used to estimate the incidence of BNP. Furthermore, in the survey of 2010, practitioners were also asked about usage of vaccine against BVDV.ResultsFrom the results of the surveys, three clusters were identified in Bavaria. These clusters also coincided with the usage of the specific BVDV vaccine as indicated by the veterinary practices. Furthermore, the representative surveys allow the estimation of the incidence of BNP to be in the order of 4 cases per 10,000 calves at risk.ConclusionsThe study is the only representative survey conducted on BNP. Despite the fact that BNP is a non-infectious disease, regional clusters were identified.

Highlights

  • Bovine neonatal pancytopenia (BNP) is a haemorrhagic disease of neonatal calves

  • Even until now, no systematic, representative investigation on the occurrence of the disease exists, neither on the spatial distribution, nor on the incidence of the disease at the herd-level. To address this knowledge gap, the aim of the current study was to describe the spatial pattern of the disease since the first cases had been reported, with a special focus on the time of the early occurrence of BNP in Bavaria, Germany

  • First survey of practitioners in July 2009 The time periods covered by the two surveys of veterinary practices coincided with the time when most cases of BNP were observed in Germany

Read more

Summary

Introduction

Bovine neonatal pancytopenia (BNP) is a haemorrhagic disease of neonatal calves. BNP was first described in Germany in 2009, later on in other European countries, and in New Zealand in 2011. We address the spatial distribution and incidence of BNP using the results of two representative surveys amongst cattle practitioners in Bavaria, Germany. Beginning in 2006, a rapidly increasing number of calves affected by a haemorrhagic syndrome was noticed within Germany [1] and subsequently in other European countries, such as Belgium [2], France [3], the UK [4], The. Netherlands [5], Italy [6] and others [7,8,9]. A depletion of cells (panmyelophthisis) was observed in histopathological examinations of the bone marrow, especially in the femur and sternum [1, 2]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.